AQU/CGNI (AQU/CGNI)

Aquis Exchange: AQU/CGNI · GBX

GBX 7.00

+0.00 (0.0%)· Recorded snapshot

Market cap	6.7M
Revenue (ttm)	7.8M
Net income (ttm)	1.1M
Shares out	96.2M
P/E (trailing)	6.1x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.8M
Net income (ttm): 1.1M
P/E (trailing): 6.1x
Market cap: 6.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E6.1

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AQU/CGNI indicators

Market & fundamental data

Available fields

122

Groups with data

Currency

GBP

Showing 122 of 122 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United Kingdom
Country code	UK
Employees	3
Employees change	-4
Employees growth	-57.14%
Enterprise value	GBX 6.6M
Exchange	Aquis Exchange
Financial currency	GBP
First seen	2026-08-28
Fiscal year end	March
Founded	2007
Industry	Biological Products, Except Diagnostic Substances
Is primary listing	Yes
ISIN number	GB00BTBLFC12
Last refreshed	2026-10-28
Market cap	GBX 6.7M
Price	GBX 7.00
Price currency	GBX
SIC code	2836
Stock price date	2026-10-27
Symbol	aqu/CGNI
Website	https://cardiogeni.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	16.29%
EV/Earnings	6.06x
EV/EBIT	2.2x
EV/EBITDA	2.13x
EV/Sales	0.85x
FCF / EV yield	-45.59%
FCF yield	-44.99%
P/B ratio	8.08x
P/E ratio	6.14x
P/S ratio	0.86x
Price / tangible book value	29.01x
Price/EBITDA ratio	2.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	38.73%
EBITDA margin	39.98%
Gross margin	100%
Operating margin	38.73%
Pretax margin	14.06%
Profit margin	14.07%
Profit per employee	GBX 365,586
Revenue per employee	GBX 2.6M
ROA	116.98%
ROCE	344.44%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	1,171.74%
Revenue growth	895.6%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	GBX 96,803
EBIT	GBX 3M
EBITDA	GBX 3.1M
FCF per share	GBX -0.03
Financing cash flow	GBX 2.8M
Free cash flow	GBX -3M
Gross profit	GBX 7.8M
Investing cash flow	GBX -13,355
Net borrowing	GBX -80,002
Net cash flow	GBX -248,412
Net income	GBX 1.1M
Operating income	GBX 3M
Revenue	GBX 7.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.3
Debt / equity	0
Long-term assets	GBX 1M
Long-term liabilities	GBX 43,200
Net cash (debt)	GBX 84,759
Net cash / market cap	1.26%
Net debt / EBITDA	-0.03
Net debt / equity	-0.1
Piotroski F-Score	4
Property, plant and equipment	GBX 426,452
Shareholders' equity	GBX 833,336
Tangible book value	GBX 231,997
Total assets	GBX 1.5M
Total cash	GBX 84,759
Total debt	GBX 0
Total liabilities	GBX 630,662

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	4.83
Current assets	GBX 432,505
Current liabilities	GBX 587,462
Current ratio	0.74
Net working capital	GBX -239,716
Quick ratio	0.74
Working capital	GBX -154,957

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	GBX 7.00
1D price change	0%
1Y price change	-22.22%
1Y return CAGR	-22.24%
1Y total return	-22.22%
20-day SMA	GBX 7.00
200-day SMA	GBX 7.00
50-day SMA	GBX 7.00
50-day SMA vs 200-day SMA	50under200
52-week high	GBX 9.00
52-week high date	2025-12-05
52-week low	GBX 7.00
52-week low date	2026-10-27
All-time high	GBX 60.00
All-time high date	2025-01-31
All-time low	GBX 5.50
All-time low date	2025-05-07
Average true range (ATR)	GBX 0.00
Average volume	0
Beta (1Y)	-0.06
Beta (2Y)	0.11
Change from 52-week high	-22.22%
Change from 52-week low	0%
Change from all-time high	-88.33%
Change from all-time low	27.27%
Monthly RSI	5.09
Previous close	GBX 7.00
Price vs 150-day SMA	0%
Price vs 20-day SMA	0%
Price vs 200-day SMA	0%
Price vs 50-day SMA	0%
RSI	0.42
Sharpe ratio	-1.53
Sortino ratio	-1.3
Weekly RSI	9.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32.5M
Shares held by insiders	66.22%
Shares held by institutions	2.08%
Shares outstanding	96.2M

Deeper analysis on AQU/CGNI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AQU/CGNI report

Is a complete AQU/CGNI research report available?

No complete published report is available for aqu/CGNI (AQU/CGNI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AQU/CGNI (AQU/CGNI)

Price

Financial snapshot

Fair-value bridge

Latest news · AQU/CGNI

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All AQU/CGNI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on AQU/CGNI

Frequently asked questions